Maryland Senate and House / 2026 Regular Session

HB0515: Public Health - Local Drug Overdose Fatality Review Teams - Membership

In the House - Hearing 2/24 at 1:00 p.m.

Requiring that the hospital representative on a local drug overdose fatality review team be a vice president, a chief medical officer, or an assistant medical officer at the hospital.

Official bill page · Source: Maryland General Assembly

Ask about HB0515

Legislative actions

No action history has been imported for this bill. This does not mean the bill had no actions.

Raw source record
{
    "Title": "Public Health - Local Drug Overdose Fatality Review Teams - Membership",
    "Status": "In the House - Hearing 2\/24 at 1:00 p.m.",
    "BillType": "Regular",
    "Sponsors": [
        {
            "Name": "Delegate Vogel"
        }
    ],
    "Statutes": [
        {
            "Article": {
                "Code": "ghg",
                "Title": "Health - General"
            },
            "Sections": [
                {
                    "Section": "5-901"
                },
                {
                    "Section": "5-902"
                }
            ]
        }
    ],
    "Synopsis": "Requiring that the hospital representative on a local drug overdose fatality review team be a vice president, a chief medical officer, or an assistant medical officer at the hospital.",
    "BillNumber": "HB0515",
    "BillVersion": "F",
    "PassedByMGA": false,
    "BroadSubjects": [
        {
            "Code": "j1",
            "Name": "Public Health"
        }
    ],
    "ChapterNumber": "",
    "EmergencyBill": false,
    "NarrowSubjects": [
        {
            "Code": "commitch",
            "Name": "Committee Changes"
        },
        {
            "Code": "death",
            "Name": "Death -see also- Homicide; Murder; Wrongful Death"
        },
        {
            "Code": "drugs",
            "Name": "Drugs -see also- Cannabis; ControlDangSubst; Pharm; etc."
        },
        {
            "Code": "health",
            "Name": "Health -see also- COVID19; EnvHlth; MedCon; etc."
        },
        {
            "Code": "healtho",
            "Name": "Health Occupations -see also- (specific health occupations)"
        },
        {
            "Code": "hospitals",
            "Name": "Hospitals -see also- Clinics; State Hospitals"
        },
        {
            "Code": "reviewb",
            "Name": "Review Boards"
        },
        {
            "Code": "substaa",
            "Name": "Substance Abuse"
        }
    ],
    "SponsorPrimary": "Delegate Vogel",
    "YearAndSession": "2026 Regular Session",
    "StatusCurrentAsOf": "2026-11-13T11:57:19.330",
    "CrossfileBillNumber": "",
    "CommitteePrimaryOrigin": "Health",
    "ConstitutionalAmendment": false,
    "ReportDateHouseOfOrigin": null,
    "ReportDateOppositeHouse": null,
    "CommitteePrimaryOpposite": "",
    "CommitteeSecondaryOrigin": "",
    "ReportActionHouseOfOrigin": "",
    "ReportActionOppositeHouse": "",
    "CommitteeSecondaryOpposite": "",
    "InteractionBetweenChambers": "",
    "FirstReadingDateHouseOfOrigin": "2026-01-27",
    "FirstReadingDateOppositeHouse": null,
    "ThirdReadingDateHouseOfOrigin": null,
    "ThirdReadingDateOppositeHouse": null,
    "SecondReadingDateHouseOfOrigin": null,
    "SecondReadingDateOppositeHouse": null,
    "ThirdReadingActionHouseOfOrigin": "",
    "ThirdReadingActionOppositeHouse": "",
    "SecondReadingActionHouseOfOrigin": "",
    "SecondReadingActionOppositeHouse": "",
    "HearingDateTimePrimaryHouseOfOrigin": "2026-02-24T13:00:00",
    "HearingDateTimePrimaryOppositeHouse": null,
    "HearingDateTimeSecondaryHouseOfOrigin": null,
    "HearingDateTimeSecondaryOppositeHouse": null
}